3rd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$137,261
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Education EDU

Teaching Health Center Graduate Medical Education, Expanding Medical Education, Rural America Health Corps Act, Doctors of Community Act, REDI Act, Resident Physician Shortage Reduction Act, Rural Physician Workforce Production Act

LobbyistCovered position, as disclosed
JACOB BRENNAN Associate Director, Regulatory Affairs and Policy
JOHN MICHAEL C. VILLARAMA Vice President, Government Affairs and Public Policy
COLIN WHITNEY New Congressional Affairs Associate

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Torts TOR

Good Samaritan Health Professionals Act, ACCESS Act, Federal COVID-19 Liability Immunity

LobbyistCovered position, as disclosed
JACOB BRENNAN Associate Director, Regulatory Affairs and Policy
JOHN MICHAEL C. VILLARAMA Vice President, Government Affairs and Public Policy
COLIN WHITNEY New Congressional Affairs Associate

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

N/A

LobbyistCovered position, as disclosed
JACOB BRENNAN Associate Director, Regulatory Affairs and Policy
JOHN MICHAEL C. VILLARAMA Vice President, Government Affairs and Public Policy
COLIN WHITNEY New Congressional Affairs Associate

Budget/Appropriations BUD

Teaching Health Center Graduate Medical Education, Expanding Medicare Medical Education, Medical Student Loan Debt, SURS Extension Act, Budget Neutrality, PAYGO

LobbyistCovered position, as disclosed
JACOB BRENNAN Associate Director, Regulatory Affairs and Policy Engagement
JOHN MICHAEL C. VILLARAMA Vice President, Government Affairs and Public Policy
COLIN WHITNEY New Congressional Affairs Associate

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE

Health Issues HCR

Graduate Medical Education, Telehealth, Physician Payment, Prior Authorization

LobbyistCovered position, as disclosed
JACOB BRENNAN Associate Director, Regulatory Affairs and Policy
JOHN MICHAEL C. VILLARAMA Vice President, Government Affairs and Public Policy
COLIN WHITNEY New Congressional Affairs Associate

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Medical/Disease Research/Clinical Labs MED

Chronic Disease Management, Gun Violence Prevention

LobbyistCovered position, as disclosed
JACOB BRENNAN Associate Director, Regulatory Affairs and Policy
JOHN MICHAEL C. VILLARAMA Vice President, Government Affairs and Public Policy
COLIN WHITNEY New Congressional Affairs Associate

Contacted: Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare Advantage Prior Authorization, Medicare Physician Payment, Expanding Medical Education, Mental Health Parity, Chronic Disease Management, SURS Extension Act, Budget Neutrality, PAYGO

LobbyistCovered position, as disclosed
JACOB BRENNAN Associate Director, Regulatory Affairs and Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs
COLIN WHITNEY New Congressional Affairs Associate

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Insurance INS

Mental Health Parity, Chronic Disease Management

LobbyistCovered position, as disclosed
JACOB BRENNAN New Associate Director, Regulatory Affairs and Policy
JOHN MICHAEL C. VILLARAMA Vice President, Government Affairs and Public Policy
COLIN WHITNEY New Congressional Affairs Associate

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.